What doctors are saying According to physicians, the goal of the Bridge program is to determine whether preventive care that treats obesity before it becomes another disease can reduce long-term costs
However, we eat for more reasons than physical hunger, and some people might continue to eat enough food that prevents them from achieving a calorie deficit due to psychological, environmental, or habitual reasons
2010: Daily injectables like liraglutide (Victoza) receive FDA approval
Semaglutide has approvals for reducing cardiovascular risks in patients with heart disease, protecting kidney function in those with chronic kidney disease, and treating metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis
doi: 10.2967/jnumed.106.038679 81 PykeCKnudsenLB
Managing Side Effects at Any Dose Even when taking the correct number of units, some patients experience mild nausea or digestive changes